Welcome to LookChem.com Sign In|Join Free
  • or
2,4-Thiazolidinedione,3-ethyl-5-(2-furanylmethylene)-(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

464903-41-1

Post Buying Request

464903-41-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

464903-41-1 Usage

Classification

Derivative of thiazolidinedione

Functional Groups

Contains a furan ring

Application

Used in pharmaceutical research

Therapeutic Properties

Potential antidiabetic agent

Mechanism of Action

May improve insulin sensitivity and reduce blood glucose levels

Research Status

Ongoing investigation into its therapeutic potential

Safety Profile

Further research and testing required to determine potential side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 464903-41-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,4,9,0 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 464903-41:
(8*4)+(7*6)+(6*4)+(5*9)+(4*0)+(3*3)+(2*4)+(1*1)=161
161 % 10 = 1
So 464903-41-1 is a valid CAS Registry Number.

464903-41-1Upstream product

464903-41-1Downstream Products

464903-41-1Relevant academic research and scientific papers

Synthesis, anti-hyperglycaemic activity, and in-silico studies of N-substituted 5-(furan-2-ylmethylene)thiazolidine-2,4-dione derivatives

Mahapatra, Manoj Kumar,Saini, Rajnish,Kumar, Manoj

, p. 8239 - 8251 (2016)

Thiazolidinedione derivatives have been used as anti-hyperglycemic agents in diabetic patients since last decade. In the present study, a series of N-substituted-5-(furan-2-ylmethylene)thiazolidine-2,4-dione derivatives were synthesized and characterized by 1H-NMR, 13C-NMR and mass spectra. The introduction of the alkyl/haloalkyl moiety onto the amidic nitrogen of the thiazolidine-2,4-dione ring was intended to enhance the anti-hyperglycaemic activity, which was further tested in vivo by using alloxan-induced diabetic laca mice. Molecular docking simulation studies further helped in understanding the nature of the interactions and the binding mode of ligands inside the active site of the protein tyrosine phosphatase 1B enzyme, which negatively regulates the insulin signaling pathway. The compounds were screened for in-vivo anti-hyperglycaemic activity in which compounds 9 and 10 have exhibited significant decreases in blood glucose level comparable to that of pioglitazone.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 464903-41-1